Top Markets
Coin of the day
IDL Diagnostics AB (publ) IDL Diagnostics AB (publ)

IDL Diagnostics AB (publ)

IDLDX
Clasificación en acciones #32452
Specializing in in vitro diagnostics (IVD), IDL Diagnostics AB (publ) develops... Specializing in in vitro diagnostics (IVD), IDL Diagnostics AB (publ) develops and markets diagnostic tests aimed at detecting cancer and bacterial infections within the Swedish market. Its product portfolio includes UBC Rapid, a point-of-care solution for both diagnosing and tracking bladder cancer; AroCell TK 210 ELISA, utilized as a biomarker for identifying tumor cells; and TUBEX TF, an in vitro diagnostic tool for pinpointing acute typhoid fever. Formerly operating as AroCell AB (publ), the company is scheduled to adopt the name IDL Diagnostics AB (publ) in May 2025. Established in 2000, its operations are headquartered in Stockholm, Sweden.
Precio por acción
$0.04367217
Capitalización bursátil
$10.06M
Cambio (1 día)
3.99%
Cambio (1 año)
-23.26%
País
SE
Comercio IDL Diagnostics AB (publ) (IDLDX)

Categoría

Ratio P/B de IDL Diagnostics AB (publ) (IDLDX)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de IDL Diagnostics AB (publ), el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de IDL Diagnostics AB (publ) desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
4.1431 -
US
2.7156 -
US
- -
CN
24.3791 -
US
27.366 -
US